• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Van Den Neste, E
    Schmitz, N
    Mounier, N
    Gill, D
    Linch, D
    Trneny, M
    Milpied, N
    Radford, John A
    Ketterer, N
    Shpilberg, O
    Dührsen, U
    Ma, D
    Brière, J
    Thieblemont, C
    Salles, G
    Moskowitz, C
    Glass, B
    Gisselbrecht, C
    Show allShow less
    Affiliation
    Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium
    Issue Date
    2015-09-14
    
    Metadata
    Show full item record
    Abstract
    Salvage chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard second-line treatment for relapsed and refractory diffuse large B-cell lymphoma (DLBCL). However, the strategy is less clear in patients who require third-line treatment. Updated outcomes of 203 patients who could not proceed to scheduled ASCT in the Collaborative Trial in Relapsed Aggressive Lymphoma (CORAL) are herein reviewed. In the intent-to-treat analysis, overall response rate to third-line chemotherapy was 39%, with 27% CR or CR unconfirmed, and 12% PR. Among the 203 patients, 64 (31.5%) were eventually transplanted (ASCT 56, allogeneic SCT 8). Median overall survival (OS) of the entire population was 4.4 months. OS was significantly improved in patients with lower tertiary International Prognostic Index (IPI), patients responding to third-line treatment and patients transplanted with a 1-year OS of 41.6% compared with 16.3% for the not transplanted (P<0.0001). In multivariate analysis, IPI at relapse (hazard ratio (HR) 2.409) and transplantation (HR 0.375) independently predicted OS. Third-line salvage chemotherapy can lead to response followed by transplantation and long-term survival in DLBCL patients. However, improvement of salvage efficacy is an urgent need with new drugs.Bone Marrow Transplantation advance online publication, 14 September 2015; doi:10.1038/bmt.2015.213.
    Citation
    Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study. 2015: Bone Marrow Transplant
    Journal
    Bone Marrow Transplantation
    URI
    http://hdl.handle.net/10541/581089
    DOI
    10.1038/bmt.2015.213
    PubMed ID
    26367239
    Type
    Article
    Language
    en
    ISSN
    1476-5365
    ae974a485f413a2113503eed53cd6c53
    10.1038/bmt.2015.213
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
    • Authors: Van Den Neste E, Schmitz N, Mounier N, Gill D, Linch D, Trneny M, Bouadballah R, Radford J, Bargetzi M, Ribrag V, Dührsen U, Ma D, Briere J, Thieblemont C, Bachy E, Moskowitz CH, Glass B, Gisselbrecht C
    • Issue date: 2017 Feb
    • Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
    • Authors: Nagle SJ, Woo K, Schuster SJ, Nasta SD, Stadtmauer E, Mick R, Svoboda J
    • Issue date: 2013 Oct
    • Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience.
    • Authors: Rassy E, Danu A, Ibrahim T, Lazarovici J, Ghez D, Michot JM, Arfi-Rouche J, Rossignol J, Vergé V, Dartigues P, Ribrag V
    • Issue date: 2021 Apr
    • Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.
    • Authors: Ferrara F, Viola A, Copia C, Schiavone EM, Celentano M, Pollio F, D'Amico MR, Palmieri S
    • Issue date: 2006 Jun
    • Management of Relapsed Diffuse Large B-cell Lymphoma.
    • Authors: Crump M
    • Issue date: 2016 Dec
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.